Retransplantation of the liver for recurrent hepatitis B virus infection: The Paul Brousse experience

Liver Transplantation and Surgery

Volumn 5, Issue 3, 1999, Pages 166-174

  Roche, B ^a   Samuel, D ^a   Feray, C ^a   Majno, P ^a   Gigou, M ^a   Reynes, M ^a   Bismuth, H ^a  

^a HÔPITAL PAUL BROUSSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; ARABINOSIDE; GANCICLOVIR; HEPATITIS B SURFACE ANTIBODY; INTERFERON; LAMIVUDINE; VIDARABINE PHOSPHATE; VIRUS DNA;

ADULT; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; FEMALE; HEPATITIS B; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER TRANSPLANTATION; MALE; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RECURRENT INFECTION; SURVIVAL RATE; VIRUS DETECTION; VIRUS HEPATITIS;

EID: 0032963475     PISSN: 10743022     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.500050304     Document Type: Article

References (35)

1. 1 Samuel D, Muller R, Alexander G, Fassati L, Ducot B, Benhamou JP, et al. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 1993 ; 329: 1842–1847. MEDLINE
2. 2 Todo S, Demetris AJ, Van Thiel D, Teperman L, Fung JJ, Starzl TE. Orthotopic liver transplantation for patients with hepatitis B virus–related liver disease. Hepatology 1991 ; 13: 619–626. MEDLINE
3. 3 O'Grady JG, Smith HM, Davies S, Daniels HM, Donaldson PT, Tan KC, et al. Hepatitis B virus re‐infection after liver transplantation: Serological and clinical implications. J Hepatol 1992 ; 14: 104–111. MEDLINE
4. 4 König V, Hopf U, Neuhaus P, Bauditz J, Schmidt CA, Blumhardt G, et al. Long‐term follow‐up of hepatitis B virus–infected recipients after orthotopic liver transplantation. Transplantation 1994 ; 58: 553–559. MEDLINE
5. 5 Davies S, Portmann B, O'Grady J, Aldis P, Chaggar K, Alexander G, et al. Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis. Hepatology 1991 ; 13: 150–157. MEDLINE
6. 6 Lau JYN, Bain VG, Davies SE, O'Grady JG, Alberti A, Alexander GJM, et al. High‐level expression of hepatitis B viral antigens in fibrosing cholestatic hepatitis. Gastroenterology 1992 ; 102: 956–962. MEDLINE
7. 7 Tur‐Kaspa R, Laub O. Corticosteroids stimulate hepatitis B virus DNA, mRNA and protein production in a stable expression system. J Hepatol 1990 ; 11: 34–36. MEDLINE
8. 8 Crippin J, Foster B, Carlen S, Borcich A, Bodenheimer H. Retransplantation in hepatitis B—A multicenter experience. Transplantation 1994 ; 57: 823–826. MEDLINE
9. 9 Terrault NA, Zhou S, Combs C, Hahn JA, Lake JR, Roberts JP, et al. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin. Hepatology 1996 ; 24: 1327–1333. MEDLINE
10. 10 Lake JR. Should liver transplantation be performed for patients with chronic hepatitis B? Yes! Liver Transpl Surg 1995 ; 1: 260–265. MEDLINE
11. 11 Kiyasu PK, Ishitani MB, McGory RW, Gaffey MJ, Dickson RC, Caldwell SH, et al. Prevention of hepatitis B “rerecurrence” after a second liver transplant—The role of maintenance polyclonal HBIg therapy. Transplantation 1994 ; 58: 954–956. MEDLINE
12. 12 Ishitani M, McGory R, Dickson R, Caldwell S, Bickston S, McCullough C, et al. Retransplantation of patients with severe posttransplant hepatitis B in the first allograft. Transplantation 1997 ; 64: 410–414. MEDLINE
13. 13 McGory RW, Ishitani M, Oliveira WM, Stevenson WC, McCullough CS, Dickson RC, et al. Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization. Transplantation 1996 ; 61: 1358–1364. MEDLINE
14. 14 Gish RG, Lau JYN, Brooks L, Fang JWS, Steady SL, Imperial JC, et al. Ganciclovir treatment of hepatitis B virus infection in liver transplant recipients. Hepatology 1996 ; 23: 1–7. MEDLINE
15. 15 Krüger M, Tillmann HL, Trautwein C, Bode U, Oldhafer K, Maschek H, et al. Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: A pilot study. Liver Transpl Surg 1996 ; 2: 253–262. MEDLINE
16. 16 Haller GW, Bechstein WO, Platz KP, Neuhaus R, Hopf U, Neuhaus P. Treatment of recurrent hepatitis B infection after liver transplantation with famciclovir [abstr]. J Hepatol 1995 ; 23: 152.
17. 17 Bain VG, Kneteman NM, Ma MM, Gutfreund K, Shapiro JA, Fischer K, et al. Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation. Tranplantation 1996 ; 62: 1456–1462.
18. 18 Grellier L, Mutimer D, Ahmed M, Brown D, Burroughs AK, Rolles K, et al. Lamivudine prophylaxis against re‐infection in liver transplantation for hepatitis B cirrhosis. Lancet 1996 ; 348: 1212–1215. MEDLINE
19. 19 Gugenheim J, Samuel D, Saliba F, Castaing D, Bismuth H. Use of flexible triple‐drug immunosuppressive therapy in liver transplantation. Transplant Proc 1987 ; 19: 3805–3807. MEDLINE
20. 20 Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. the METAVIR Cooperative Study Group. Hepatology 1996 ; 24: 289–293. MEDLINE
21. 21 Samuel D, Bismuth A, Mathieu D, Arulnaden JL, Reynes M, Benhamou JP, et al. Passive immunoprophylaxis after liver transplantation in HBsAg‐positive patients. Lancet 1991 ; 337: 813–815. MEDLINE
22. 22 Gugenheim J, Crafa F, Fabiani P, Goubaux B, Ouzan D, Mouiel J. Long‐term passive immunoprophylaxis of B virus recurrence after liver transplantation in Hbs antigen–positive patients. Transplant Proc 1993 ; 25: 1349–1350. MEDLINE
23. 23 Muller R, Gubernatis G, Farle M, Niehoff G, Klein H, Wittekind C. Liver transplantation in Hbs antigen (HBsAg) carriers: Prevention of hepatitis B virus (HBV) recurrence by passive immunization. J Hepatol 1991 ; 13: 90–96. MEDLINE
24. 24 Mora N, Klintmalm G, Poplawski S, Cofer J, Husberg B, Gonwa TA, et al. Recurrence of hepatitis B after liver transplantation: Does hepatitis B immunoglobulin modify the recurrent disease? Transplant Proc 1990 ; 22: 1549–1550. MEDLINE
25. 25 Rimoldi P, Belli L, Rondinara G, Alberti A, DeCarlis L, Minola E. Recurrent HBV/HDV infections under different immunoprophylaxis protocols. Transplant Proc 1993 ; 25: 2675–2676. MEDLINE
26. 26 Marcellin P, Samuel D, Loriot MA, Areias J, Bismuth H, Benhamou JP. Anti‐viral effect of adenine arabinoside monophosphate (ara‐Amp) in patients with recurrence of hepatitis B virus (HBV) infection after liver transplantation [abstr]. Hepatology 1990 ; 12: 966A.
27. 27 Terrault NA, Holland CC, Ferrell L, Hahn JA, Lake JR, Roberts JP, et al. Interferon alfa for recurrent hepatitis B infection after liver transplantation. Liver Transpl Surg 1996 ; 2: 132–138. MEDLINE
28. 28 Feray C, Samuel D, Gigou M, Paradis V, David MF, Lemonnier C, et al. An open trial of interferon alpha recombinant for hepatitis C after liver transplantation: Anti‐viral effects and risk of rejection. Hepatology 1995 ; 22: 1084–1089. MEDLINE
29. 29 Marcellin P, Samuel D, Areias J, Loriot MA, Arulnaden JL, Gigou M, et al. Pretransplantation interferon treatment and recurrence of hepatitis B virus infection after liver transplantation for hepatitis B–related end‐stage liver disease. Hepatology 1994 ; 19: 6–12. MEDLINE
30. 30 Dienstag JL, Perrillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin M. A preliminary trial of lamivudine for chronic hepatitis B virus infection. N Engl J Med 1995 ; 333: 1657–1661. MEDLINE
31. 31 Perrillo RP, Rakela J, Martin P, Levy GL, Schiff ER, Wright T, et al. Lamivudine for hepatitis B after liver transplantation. Hepatology 1996 ; 24: 182A.
32. 32 Ling R, Mutimer D, Ahmed M, Boxall EH, Elias E, Dusheiko GM, et al. Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine. Hepatology 1996 ; 24: 711–713. MEDLINE
33. 33 Wang Y, Bowden DS, Shaw T, Civitico G, Chan Y, Qiao M, et al. Inhibition of duck hepatitis B virus replication in vivo by the nucleoside analogue ganciclovir. Antiviral Chem Chemother 1991 ; 2: 107–114.
34. 34 Chossegros P, Pouteil‐Noble C, Samuel D, Causse X, Ouzan D, Bizollon T, et al. Ganciclovir is an effective anti‐viral agent for post‐transplantation chronic HBV infections, maintenance therapy may be required in some cases [abstr]. Gastroenterology 1993 ; 104: A888.
35. 35 De la Mata M, Montero JL, Fraga E, Costan G, Delgado M, Lopez R, et al. Efficacy of ganciclovir in the treatment of hepatitis B virus infection of the liver graft. Long‐term results [abstr]. Hepatology 1995 ; 22: 130A.